ARTES Biotechnology issued New Patent in Australia for VLP Technology
ARTES Biotechnology specialized in microbial cell line and process development as well as in technology transfer for pha…
ARTES Biotechnology specialized in microbial cell line and process development as well as in technology transfer for pha…
Artes and PAC join forces and combine their technologies and know-how. ARTES Biotechnology specializes in recombinant p…
ARTES Biotechnology, specialized in recombinant protein production and process development in microbial expression syste…
ARTES Biotechnology announces today the acquirement of the ANAVAX virus-like particle (VLP) technology from Select Vacci…
Q Chip Ltd and ARTES Biotechnology GmbH announce that they have signed a Collaborative Agreement to explore the co-devel…
ARTES Biotechnology GmbH, Spezialist für die Entwicklung rekombinanter Proteine und Prozesse in Hefen, und Rhein Minapha…
ARTES Biotechnology, specialized in recombinant protein production and process development from yeast expression systems…
ARTES announced today that it has signed an exclusive Marketing Agreement with the Institute of Cell Biology of the Nati…
ARTES Biotechnology GmbH today announces the collaboration with Henkel in a joint three years research program that is g…
ARTES Biotechnology GmbH gab heute ihre Zusammenarbeit mit Henkel im Rahmen eines dreijährigen Forschungsvorhabens bekan…